Astellas Pharma Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2038
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:132
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Astellas Pharma Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Astellas Pharma Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Astellas Pharma Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Astellas Pharma Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Astellas Pharma Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Astellas Pharma Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Astellas Pharma Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Astellas Pharma Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 14
Mergers and Acquisitions – Overview 14
Mergers and Acquisitions – Deal reports 15
CORPORATE VENTURING 22
Corporate Venturing – Overview 22
Corporate Venturing – Deal reports 23
PARTNERSHIP 27
Partnership – Overview 27
Partnership – Deal reports 28
DIVESTMENTS 117
Divestments – Overview 117
Divestments – Deal reports 118
APPENDIX 122
Contact Us 122
About MarketLine Financial Deals Database 122
Deal Definition and Methodology 124
About MarketLine 131

List of Tables
Table 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Table 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Table 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Table 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Table 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Table 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Figure 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Astellas Pharma Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GE Power India Ltd:企業の戦略・SWOT・財務情報
    GE Power India Ltd - Strategy, SWOT and Corporate Finance Report Summary GE Power India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • J.L. Clark Inc:企業の戦略的SWOT分析
    J.L. Clark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • RigNet Inc (RNET):石油・ガス:M&Aディール及び事業提携情報
    Summary RigNet Inc (RigNet) is a technology company that provides applications, customized communication services and cyber security solutions. Its managed services include remote communications and technology services for onshore and offshore drilling rigs, support vessels, production facilities, a …
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • Olympia Vodice d.d.:企業の戦略・SWOT・財務情報
    Olympia Vodice d.d. - Strategy, SWOT and Corporate Finance Report Summary Olympia Vodice d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a brand of MKS Instruments Equipment & Solutions Division, which offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, mem …
  • The Kansai Electric Power Company Inc:発電所・企業SWOT分析
    The Kansai Electric Power Company Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • SRS Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables products c …
  • Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務分析
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kuwait Investment Authority:電力:M&Aディール及び事業提携情報
    Summary The Kuwait Investment Authority (KIA) is an asset management company. It offers fund management and investment management services. The company is responsible for the management and administration of the General Reserve Fund (GRF), apart from the assets of the Future Generations Fund (FGF). …
  • H&R Block, Inc.:戦略・SWOT・企業財務分析
    H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report Summary H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TESARO Inc (TSRO):医療機器:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Patterson Companies Inc (PDCO):医療機器:M&Aディール及び事業提携情報
    Summary Patterson Companies, Inc. (Patterson) is a distributor of dental and veterinary products, services and technologies. It provides products to the production and companion animal health markets. The company’s product portfolio comprises restorative materials, hand instruments, sterilization pr …
  • C. Uyemura & Co Ltd (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co Ltd (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Scientific Games Corporation:企業の戦略・SWOT・財務情報
    Scientific Games Corporation - Strategy, SWOT and Corporate Finance Report Summary Scientific Games Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • China Railway Construction Corporation Ltd:戦略・SWOT・企業財務分析
    China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Construction Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆